Outcome | Age 16–25 OR (95% CI p value) | Age 26–35 OR (95% CI p value) | Age 36–45 OR (95% CI p value) | Age 46–55 OR (95% CI p value) | All OR (95% CI p value) |
---|---|---|---|---|---|
Age per 5 years | 0.73 (0.43–1.23, 0.23) | 1.26 (0.88–1.80, 0.20) | 1.51 (1.19–1.93, < 0.01) | 1.23 (1.04–1.44, 0.01) | 1.14 (1.09–1.18, < 0.01) |
AKI | 2.48 (1.25–4.90, < 0.01) | 1.65 (0.98–2.79, 0.05) | 2.06 (1.44–2.95, < 0.01) | 2.00 (1.56–2.56, < 0.01) | 2.03 (1.69–2.43, < 0.01) |
APACHE III score | 1.03 (1.01–1.03, < 0.01) | 1.03 (1.02–1.03, < 0.01) | 1.03 (1.02–1.03, < 0.01) | 1.03 (1.02–1.03, < 0.01) | 1.03 (1.03–1.04, < 0.01 |
Hypotensive Index | 1.01 (1.01–1.02, < 0.01) | 1.00 (0.99–1.01, 0.12) | 1.00 (1.00–1.01, < 0.01) | 1.00 (1.00–1.00, < 0.01) | 1.01 (1.01–1.01, < 0.01) |
Vasopressors | 3.28 (1.60–6.75, < 0.01) | 3.98 (2.46–6.43, < 0.01) | 2.46 (1.79–3.38, < 0.01) | 1.97 (1.61–2.42, < 0.01) | 2.30 (2.0–2.7, < 0.01) |
Surgical Admission | 0.63 (0.35–1.15, < 0.01) | 0.66 (0.43–1.01, 0.05) | 0.54 (0.41–0.71, < 0.01) | 0.60 (0.49–0.72, < 0.01) | 0.60 (0.51–0.68, < 0.01) |
Moderate anemia | 1.12 (0.60–2.11, 0.72) | 0.81 (0.51–1.3, 0.39) | 0.87 (0.64–1.19, 0.41) | 0.86 (0.70–1.05, 0.14) | 0.87 (0.75–1.01, 0.07) |
Hypertension | 0.76 (0.21–2.69, 0.67) | 0.85 (0.42–1.72, 0.65) | 0.89 (0.61–1.30, 0.57) | 0.94 (0.74–1.18, 0.59) | 0.89 (0.74–1.07, 0.20) |
Malignancy | 5.23 (1.47–18.61, 0.01) | 2.55 (1.09–5.94, 0.02) | 1.80 (1.10–2.96, 0.01) | 1.52 (1.12–2.05, 0.00) | 1.68 (1.32–2.14, < 0.01) |
Chronic liver disease | 0.61 (0.06–6.01, 0.67) | 1.37 (0.57–3.25, 0.47) | 1.49 (0.93–2.4, 0.09) | 1.56 (1.17–2.08, 0.00) | 1.47 (1.16–1.85, < 0.01) |
Multiple comorbidities | 1.27 (0.51–3.17, 0.60) | 1.58 (0.87–2.88, 0.13) | 1.18 (0.80–1.73, 0.38) | 0.82 (0.63–1.06, 0.13) | 1.02 (0.84–1.24, 0.84) |
AUC (Q1–Q3) | 0.895 (0.854–0.932) | 0.8942 (0.868–0.920) | 0.8855 (0.868–0.902) | 0.853 (0.838–0.867) | 0.875 (0.865–0.884) |